v3.26.1
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 767 [1] $ 1,007,483 $ (1,038,713) $ (30,463)
Balance (in Shares) at Dec. 31, 2025 7,666,667 [1]      
Accretion for Class A Ordinary Shares to redemption amount [1] $ (8,644,049) $ (889,949) $ (9,533,998)
Sale of Private Placement Warrants [1] 4,125,000 4,125,000
Fair value of public warrants at issuance [1] $ 3,526,667 $ 3,526,667
Fair value of transferred Founder Shares to the advisor [1] 85,500 85,500
Allocated value of transaction costs to Class A shares [1] (100,601) (100,601)
Net income [1] 899,846 899,846
Balance at Mar. 31, 2026 $ 767 [1] (1,028,816) (1,028,049)
Balance (in Shares) at Mar. 31, 2026 7,666,667 [1]      
Balance at Dec. 31, 2025 $ 767 [1] 1,007,483 (1,038,713) (30,463)
Balance (in Shares) at Dec. 31, 2025 7,666,667 [1]      
Net income         2,828,130
Balance at Jun. 30, 2026 $ 767 [1] (1,145,095) (1,144,328)
Balance (in Shares) at Jun. 30, 2026 7,666,667      
Balance at Mar. 31, 2026 $ 767 [1] (1,028,816) (1,028,049)
Balance (in Shares) at Mar. 31, 2026 7,666,667 [1]      
Accretion for Class A Ordinary Shares to redemption amount [1] (2,044,563) (2,044,563)
Net income [1] 1,928,284 1,928,284
Balance at Jun. 30, 2026 $ 767 [1] $ (1,145,095) $ (1,144,328)
Balance (in Shares) at Jun. 30, 2026 7,666,667      
[1] As of December 31, 2025, includes 1,000,000 Class B Ordinary Shares that were subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On February 12, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,000,000 founder shares are no longer subject to forfeiture (Note 7).